Biography

Nicole Frahm earned her PhD in Immunology from the University of Hamburg and completed postdoctoral work in HIV pathogenesis at Massachusetts General Hospital. She later served as Associate Director for Laboratory Science at the HIV Vaccine Trials Network. In her role as the Head of Bioassay and Biomarker Development at the Gates MRI, she defines assay strategies aiming to support regulated clinical endpoints, as well as the identification of correlates of protection for vaccines and predictive biomarkers for drug efficacy, including the evaluation, prioritization and implementation of cutting-edge technologies with a particular focus on systems biology tools.